{"id":2893,"date":"2023-03-31T15:02:44","date_gmt":"2023-03-31T15:02:44","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=2893"},"modified":"2023-03-31T15:02:45","modified_gmt":"2023-03-31T15:02:45","slug":"pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/","title":{"rendered":"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders"},"content":{"rendered":"
\n
\"\"<\/figure><\/div>\n\n\n

Pragma Bio<\/a> is a biotechnology startup based in South San Francisco, California, with a mission to find cures for undruggable immunological disorders. With $10 million in funding from investors such as The Venture Collective (TVC)<\/a> and Viking Global Investors<\/a>, the company aims to revolutionize how we approach treatments for these disorders.<\/p>\n\n\n\n

Using a combination of real-world data and synthetic biology, Pragma Bio can map out multi-omic signatures associated with clinical outcomes, which allows them to identify microbial-derived small molecules with therapeutic potential. By leveraging these small molecules, the company aims to produce effective treatments for immunological disorders that were previously considered incurable.<\/p>\n\n\n\n

\"The<\/figure>\n\n\n\n

The potential for this type of approach is immense, as many immunological disorders lack effective treatments due to their complexity and the difficulty of targeting specific cells or biological pathways. <\/p>\n\n\n\n

\"Meet<\/figure>\n\n\n\n

Pragma Bio\u2019s innovative approach has the potential to address these challenges and provide new hope for patients suffering from these conditions. Visit us for more information about their latest funding round: https:\/\/founderlodge.com\/round\/Pragma-Bio-raises-10000000-Unknown-2023-03-27-Kareem-Barghouti-MTE0OTg<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Pragma Bio is a biotechnology startup based in South San Francisco, California, with a mission to find cures for undruggable immunological disorders. With $10 million in funding from investors such as The Venture Collective (TVC) and Viking Global Investors, the company aims to revolutionize how we approach treatments for these disorders. Using a combination of […]<\/p>\n","protected":false},"author":3,"featured_media":2897,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[394,527],"yoast_head":"\nPragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders - Founder Lodge Latest News<\/title>\n<meta name=\"description\" content=\"Pragma Bio is a biotechnology startup based in South San Francisco, California, with a mission to find cures for undruggable immunological disorders. With\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders - Founder Lodge Latest News\" \/>\n<meta property=\"og:description\" content=\"Pragma Bio is a biotechnology startup based in South San Francisco, California, with a mission to find cures for undruggable immunological disorders. With\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-31T15:02:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-31T15:02:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/Screenshot-1067.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1326\" \/>\n\t<meta property=\"og:image:height\" content=\"639\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ayesha Kanwal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ayesha Kanwal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/\"},\"author\":{\"name\":\"Ayesha Kanwal\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/84b30b34a96b8f66e08acd79b29fc198\"},\"headline\":\"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders\",\"datePublished\":\"2023-03-31T15:02:44+00:00\",\"dateModified\":\"2023-03-31T15:02:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/\"},\"wordCount\":186,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"keywords\":[\"funding from investors\",\"Pragma\"],\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/\",\"name\":\"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders - Founder Lodge Latest News\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-03-31T15:02:44+00:00\",\"dateModified\":\"2023-03-31T15:02:45+00:00\",\"description\":\"Pragma Bio is a biotechnology startup based in South San Francisco, California, with a mission to find cures for undruggable immunological disorders. With\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who's raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/84b30b34a96b8f66e08acd79b29fc198\",\"name\":\"Ayesha Kanwal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7657d62981ef50c7c94f042b91db49ad?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7657d62981ef50c7c94f042b91db49ad?s=96&d=mm&r=g\",\"caption\":\"Ayesha Kanwal\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/aisha\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders - Founder Lodge Latest News","description":"Pragma Bio is a biotechnology startup based in South San Francisco, California, with a mission to find cures for undruggable immunological disorders. With","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/","og_locale":"en_US","og_type":"article","og_title":"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders - Founder Lodge Latest News","og_description":"Pragma Bio is a biotechnology startup based in South San Francisco, California, with a mission to find cures for undruggable immunological disorders. With","og_url":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-03-31T15:02:44+00:00","article_modified_time":"2023-03-31T15:02:45+00:00","og_image":[{"width":1326,"height":639,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/Screenshot-1067.png","type":"image\/png"}],"author":"Ayesha Kanwal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ayesha Kanwal","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/"},"author":{"name":"Ayesha Kanwal","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/84b30b34a96b8f66e08acd79b29fc198"},"headline":"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders","datePublished":"2023-03-31T15:02:44+00:00","dateModified":"2023-03-31T15:02:45+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/"},"wordCount":186,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"keywords":["funding from investors","Pragma"],"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/","url":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/","name":"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders - Founder Lodge Latest News","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-03-31T15:02:44+00:00","dateModified":"2023-03-31T15:02:45+00:00","description":"Pragma Bio is a biotechnology startup based in South San Francisco, California, with a mission to find cures for undruggable immunological disorders. With","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/pragma-bio-secures-10m-to-develop-microbial-derived-small-molecules-for-undruggable-immunological-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Pragma Bio Secures $10M to Develop Microbial-Derived Small Molecules for Undruggable Immunological Disorders"}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who's raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/84b30b34a96b8f66e08acd79b29fc198","name":"Ayesha Kanwal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7657d62981ef50c7c94f042b91db49ad?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7657d62981ef50c7c94f042b91db49ad?s=96&d=mm&r=g","caption":"Ayesha Kanwal"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/aisha\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/2893"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=2893"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/2893\/revisions"}],"predecessor-version":[{"id":2898,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/2893\/revisions\/2898"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/2897"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=2893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=2893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=2893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}